Home Financial Markets Penny Stocks What Has Uplifted the CytoDyn (CYDY) Stock 15% In The Last Session?

What Has Uplifted the CytoDyn (CYDY) Stock 15% In The Last Session?

Stock late-stage biotechnology company CytoDyn Inc. (OTCQB: CYDY) surged by 14.95% in the last session bring the share price to $2.46 at the close of the market. The stock has been trading in a day range of $2.5700 to $2.0000.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

Performance in brief:

A share price decline of over -61.51% occurred in the last month; with more than 6.28 million shares on average traded in that time. If we look at the performance of CYDY stock over three months, the stock plunged by -21.66% with 5.81M shares traded on average. Stock price in the last 12 months has grown by over 152.53%, with a high of $10.010 and a market cap of $1.50B.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

Company’s profile:

This late-stage biotech firm develops innovative treatments based on humanized monoclonal antibodies targeted to the CCR5, the target of the company’s new treatment, leronlimab. There is strong evidence that CCR5 plays a vital role in the ability for HIV to enter healthy T-cells and infect them. Furthermore, the CCR5 receptor has been implicated in infectious diseases such as GvHD and NASH, in addition to tumor metastasis.

What took the stock higher?

CytoDyn Inc., in a press release today announced the administration of a dosage of in Phase 2 trial being conducted by the company currently. Stocks rose in the last trading session as a result of this positive news. Following are some highlights from the company’s press release about the ongoing trials:

  • 20 patients received doses for the COVID-19 long-haulers symptoms in the first ten days of the Phase 2 trial conducted by CytoDyn Inc.
  • A total of 50 people are expected to take part in the trial.
  • A total of eight weekly doses will be administered to each patient, followed by a safety evaluation that span around four weeks.
  • Data from the trial are expected by mid-summer 2021, with the endpoint measured on Day 56.
  • This Phase 2 double-blind, randomized placebo-controlled trial is designed to evaluate the efficacy and safety of leronlimab in patients (Long-Haulers) suffering prolonged symptoms of coronavirus disease.

    Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

Last but not least,

CytoDyn Inc. (CYDY) believes that leronlimab will succeed for many indications, thanks to strong CD12 results and NASH and long-hauler data that are at the forefront of the pipeline, and its potential for HIV just around the corner. And that will not only be improving the returns of CYDY’s shareholders but will also bolster the company’s growth.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

The Clorox Company Ltd. (CLX) stock decline during pre-market. Here’s the recent update

The Clorox Company Ltd. (NASDAQ: CLX) stock gained by 0.17% at last close whereas the CLX stock price fell by 11.59% in the pre-market....

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

OneConnect Financial Technology Inc. (OCFT) stock plunge during current market. Here’s what you should know.

OneConnect Financial Technology Inc. (NASDAQ: OCFT) stock declines by 22.12% in the current market trading. In China, OneConnect is the most popular technology-as-a-service platform...

Invitae Corporation Inc. (NVTA) stock surge during current market. Here’s the update:

Invitae Corporation Inc. (NASDAQ: NVTA) stock gains by 12.35% in the current market trading session. Invitae Corporation is a prominent medical genetics business whose...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

Related News

What Caused The Sino United Worldwide (SUIC) Stock To Drop 50%?

In the last session, the price of Sino United Worldwide Consolidated Ltd (OTCPink: SUIC) spiraled -50.82% to $5.4000. During the session, Sino United's stock...

On What Basis Did HIRU Stock Rise 43%?

Hiru Corp stock blasted into the green at the previous close, rising 43.00% to $0.0143. Volume was 65.87 million against 30-day Average Volume...

Is There Any Reason As To Why The BIGG Digital (BBKCF) Stock Expanded By 30%?

A share of BIGG Digital Assets Inc (OTCQX: BBKCF) rose 30.78 at yesterday's close, to $1.4670. There was an increase in volume of BIGG...

Why Has The Ascot (AOTVF) Stock Price Gained 20%?

The stock of Ascot Resources Ltd (OTCQX: AOTVF) gained significantly as it increased by 20.50% to $0.8858 at last close. The Ascot stock price...

How Does The KinerjaPay (KPAY) Stock Price Increase By 454%?

The payment gateway and eCommerce company KierjaPay Corporation (OTCPink: KPAY) closed Tuesday's trading session at $0.0122, up 454.55%, and has been trading in a...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam